SCHEMBL7200852

SCHEMBL7200852

c1ccn(Cc2ccc(Oc3ccc(CN4CCCC4)cc3)cc2)c1

nearest known ligand 0.56

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 11/20 0.55
TSHR P16473 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C19 P33261 1/20 0.50
HRH4 Q9H3N8 1/20 0.50
ACHE P22303 1/20 0.50
RAD52 P43351 1/20 0.50
LTA4H P09960 1/20 0.49
PTGIR P43119 1/20 0.49
ALDH1A1 P00352 2/20 0.49
KDM4E B2RXH2 1/20 0.49
MBTD1 Q05BQ5 1/20 0.47
L3MBTL3 Q96JM7 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
SIGMAR1 Q99720 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6057540 0.89 HRH3 (0.68) HRH3CYP2D6CYP2C19HRH4ALDH1A1
SCHEMBL6057466 0.88 HRH3 (0.71) HRH3TSHRCYP2D6CYP2C19HRH4
SCHEMBL6057519 0.86 HRH3 (0.77) HRH3
SCHEMBL6057447 0.86 HRH3 (0.75) HRH3TSHRCYP2D6CYP2C19HRH4
SCHEMBL6058205 0.86 HRH3 (0.75) HRH3TSHRCYP2D6CYP2C19HRH4
SCHEMBL3041586 0.77 ALDH1A1 (0.69) HRH3TSHRHRH4ACHERAD52
SCHEMBL6057443 0.77 ALDH1A1 (0.58) HRH3TSHRHRH4ACHERAD52
SCHEMBL3041814 0.76 HRH3 (0.57) HRH3TSHRHRH4ACHERAD52
SCHEMBL11201497 0.75 HRH3 (0.94) HRH3CYP2D6CYP2C19HRH4ALDH1A1
SCHEMBL4419477 0.74 ALDH1A1 (0.63) HRH3TSHRCYP2D6CYP2C19ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1311499-A2 BICYCLIC COMPOUNDS AS H3 RECEPTOR LIGANDS Ortho-McNeil Pharmaceutical, Inc. (US) 2003-05-21 EP disclosed
WO-2002012224-A2 BICYCLIC COMPOUNDS AS H3 RECEPTOR LIGANDS ORTHO MCNEIL PHARMACEUTICAL, INC. (US) 2002-02-14 WO disclosed